3-methoxyursolic acid - Compound Card

3-methoxyursolic acid

Select a section from the left sidebar

3-methoxyursolic acid

Structure
Zoomed Structure
  • Family: Plantae - Apocynaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Pentacyclic Triterpene
Canonical Smiles CO[C@]1(O)CC[C@]2(C(C1(C)C)CC[C@@]1([C@@H]2CC=C2[C@@]1(C)CC[C@@]1([C@H]2[C@@H](C)[C@H](C)CC1)C(=O)O)C)C
InChI InChI=1S/C31H50O4/c1-19-11-14-30(25(32)33)17-16-28(6)21(24(30)20(19)2)9-10-23-27(5)15-18-31(34,35-8)26(3,4)22(27)12-13-29(23,28)7/h9,19-20,22-24,34H,10-18H2,1-8H3,(H,32,33)/t19-,20+,22?,23-,24+,27+,28-,29-,30+,31-/m1/s1
InChIKey OKDBLJCYTKVVCD-CUVXTANGSA-N
Formula C31H50O4
HBA 3
HBD 2
MW 486.74
Rotatable Bonds 2
TPSA 66.76
LogP 7.06
Number Rings 5
Number Aromatic Rings 0
Heavy Atom Count 35
Formal Charge 0
Fraction CSP3 0.9
Exact Mass 486.37
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Tabernaemontana contorta Apocynaceae Plantae 761060

Showing of synonyms

  • Foudjo Melacheu G, Mfotie Njoya E, et al. (2019). Two new indole alkaloids from Tabernaemontana contorta Stapf. Phytochemistry Letters, 2019, 30, 116-119. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 486.74 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.32
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.850
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.8

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
1.930
Plasma Protein Binding
94.91
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
2.120
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-0.630
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
1.800
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
3.040
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Toxic
T. Pyriformis
-222.160
Rat (Acute)
2.370
Rat (Chronic Oral)
1.870
Fathead Minnow
3.810
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
461.420
Hydration Free Energy
-2.620
Log(D) at pH=7.4
4.720
Log(P)
6.31
Log S
-6.31
Log(Vapor Pressure)
-9.33
Melting Point
258.5
pKa Acid
5.55
pKa Basic
7.44

No predicted protein targets found for this compound.

Download SDF